Advanced

Hemodynamic effects by glucagon-like peptide-1 receptor analogues : What should be measured?

Nilsson, Peter M. LU (2017) In Journal of Hypertension 35(5). p.953-954
Please use this url to cite or link to this publication:
author
organization
publishing date
type
Contribution to journal
publication status
published
subject
in
Journal of Hypertension
volume
35
issue
5
pages
953 - 954
publisher
Lippincott Williams & Wilkins
external identifiers
  • scopus:85017335775
  • wos:000401265800007
ISSN
0263-6352
DOI
10.1097/HJH.0000000000001315
language
English
LU publication?
yes
id
c754dd36-fdfc-4754-bd8e-f4b1780a4ada
date added to LUP
2017-05-04 17:04:59
date last changed
2017-09-18 13:34:09
@misc{c754dd36-fdfc-4754-bd8e-f4b1780a4ada,
  author       = {Nilsson, Peter M.},
  issn         = {0263-6352},
  language     = {eng},
  number       = {5},
  pages        = {953--954},
  publisher    = {Lippincott Williams & Wilkins},
  series       = {Journal of Hypertension},
  title        = {Hemodynamic effects by glucagon-like peptide-1 receptor analogues : What should be measured?},
  url          = {http://dx.doi.org/10.1097/HJH.0000000000001315},
  volume       = {35},
  year         = {2017},
}